Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 429290, 7 pages
http://dx.doi.org/10.1155/2015/429290
Research Article

Predictors for Early Identification of Hepatitis C Virus Infection

1Kaohsiung Blood Center, Taiwan Blood Services Foundation, Kaohsiung 811, Taiwan
2Department of Medical Laboratory Science and Biotechnology, College of Health Sciences, Kaohsiung Medical University, Kaohsiung 807, Taiwan
3Department of Clinical Laboratory, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan
4Cishan Hospital, Ministry of Health and Welfare, Kaohsiung 842, Taiwan
5Department of Medical Imaging and Radiological Sciences, College of Health Sciences, Kaohsiung Medical University, Kaohsiung 807, Taiwan
6Translational Research Center, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan
7Institute of Medical Science and Technology, National Sun Yat-Sen University, Kaohsiung 804, Taiwan
8Department of Anesthesiology, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine, Kaohsiung 833, Taiwan
9Department of Biological Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan
10Edward Francis Small Teaching Hospital, Banjul 1515, Gambia
11Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan
12Department of Obstetrics and Gynecology, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan
13School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan
14Department of Laboratory Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan

Received 8 September 2014; Accepted 28 November 2014

Academic Editor: Mohammad Ahmad Al-Shatouri

Copyright © 2015 Mei-Hua Tsai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. C. Cowie, K. S. Carville, and J. H. MacLachlan, “Mortality due to viral hepatitis in the global burden of disease study 2010: new evidence of an urgent global public health priority demanding action,” Antiviral Therapy, vol. 18, no. 8, pp. 953–954, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. H. B. El-Serag and K. L. Rudolph, “Hepatocellular carcinoma: epidemiology and molecular carcinogenesis,” Gastroenterology, vol. 132, no. 7, pp. 2557–2576, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. J. McCombs, T. Matsuda, I. Tonnu-Mihara et al., “The risk of long-term morbidity and mortality in patients with chronic hepatitis C: results from an analysis of data from a department of veterans affairs clinical registry,” JAMA Internal Medicine, vol. 174, no. 2, pp. 204–212, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Trepo, “A brief history of hepatitis milestones,” Liver International, vol. 34, supplement 1, pp. 29–37, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. C.-H. Chen, P.-M. Yang, G.-T. Huang, H.-S. Lee, J.-L. Sung, and J.-C. Sheu, “Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants,” Journal of the Formosan Medical Association, vol. 106, no. 2, pp. 148–155, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. J. H. Wang, S. N. Lu, J. C. Wu et al., “A hyperendemic community of hepatitis B virus and hepatitis C virus infection in Taiwan,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 93, no. 3, pp. 253–254, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. C. A. Sun, H. C. Chen, C. F. Lu et al., “Transmission of hepatitis C virus in Taiwan: prevalence and risk factors based on a nationwide survey,” Journal of Medical Virology, vol. 59, no. 3, pp. 290–296, 1999. View at Google Scholar
  8. C.-M. Lee, S.-N. Lu, C.-H. Hung et al., “Hepatitis C virus genotypes in southern Taiwan: prevalence and clinical implications,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 100, no. 8, pp. 767–774, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Simmonds, F. McOmish, P. L. Yap et al., “Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey,” Journal of Clinical Microbiology, vol. 32, no. 4, pp. 884–892, 1994. View at Google Scholar · View at Scopus
  10. M.-H. Lee, H.-I. Yang, S.-N. Lu et al., “Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study,” The Journal of Infectious Diseases, vol. 206, no. 4, pp. 469–477, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. K. E. Nelson, “The impact of chronic hepatitis C virus infection on mortality,” Journal of Infectious Diseases, vol. 206, no. 4, pp. 461–463, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. J. W. Ward, “The hidden epidemic of hepatitis C virus infection in the United States: occult transmission and burden of disease,” Topics in Antiviral Medicine, vol. 21, no. 1, pp. 15–19, 2013. View at Google Scholar · View at Scopus
  13. N. Mühlberger, R. Schwarzer, B. Lettmeier, G. Sroczynski, S. Zeuzem, and U. Siebert, “LHCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality,” BMC Public Health, vol. 9, article 34, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. B. D. Smith, R. L. Morgan, G. A. Beckett et al., “Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945–1965,” MMWR: Recommendations and Reports, vol. 61, no. RR-4, pp. 1–32, 2012. View at Google Scholar
  15. L. B. Seeff, “Natural history of chronic hepatitis C,” Hepatology, vol. 36, no. 5, supplement 1, pp. S35–S46, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. F.-B. Wu, H.-Q. Ouyan, X.-Y. Tang, and Z.-X. Zhou, “Double-antigen sandwich time-resolved immunofluorometric assay for the detection of anti-hepatitis C virus total antibodies with improved specificity and sensitivity,” Journal of Medical Microbiology, vol. 57, no. 8, pp. 947–953, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. M. A. El Barbary, A. E. M. Saad, F. M. Attia et al., “Thrombocytopenia in patients with chronic hepatitis C: a possible role of hcv on platelet progenitor cell maturation,” Angiology, vol. 61, no. 3, pp. 304–313, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. T. L. Kauf, D. R. Nelson, J. Schelfhout, J. A. Delaney, and P. F. Wang, “Trends in the prevalence of thrombocytopenia among individuals iInfected with hepatitis C Virus in the United States, 1999–2008,” BMC Research Notes, vol. 5, article 142, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. M.-C. Tsai, K.-M. Kee, Y.-D. Chen et al., “Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV-endemic areas in an HBV-endemic country: geographic variations among 502 villages in southern Taiwan,” Journal of Gastroenterology and Hepatology (Australia), vol. 22, no. 1, pp. 92–98, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. C.-S. Wang, W.-J. Yao, S.-T. Wang, T.-T. Chang, and P. Chou, “Strong association of hepatitis C virus (HCV) infection and thrombocytopenia: implications from a survey of a community with hyperendemic HCV infection,” Clinical Infectious Diseases, vol. 39, no. 6, pp. 790–796, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. X. Li, L. J. Jeffers, C. Garon et al., “Persistence of hepatitis C virus in a human megakaryoblastic leukaemia cell line,” Journal of Viral Hepatitis, vol. 6, no. 2, pp. 107–114, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Giannini, F. Botta, P. Borro et al., “Relationship between thrombopoietin serum levels and liver function in patients with chronic liver disease related to hepatitis C virus infection,” The American Journal of Gastroenterology, vol. 98, no. 11, pp. 2516–2520, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Kawasaki, A. Takeshita, K. Souda et al., “Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis,” The American Journal of Gastroenterology, vol. 94, no. 7, pp. 1918–1922, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Hobisch-Hagen, W. Jelkmann, A. Mayr et al., “Low platelet count and elevated serum thrombopoietin after severe trauma,” European Journal of Haematology, vol. 64, no. 3, pp. 157–163, 2000. View at Google Scholar
  25. A. Karmen, F. Wróblewski, and S. LaDue, “Transaminase activity in human blood,” The Journal of Clinical Investigation, vol. 34, no. 1, pp. 126–131, 1955. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Puoti, R. Castellacci, F. Montagnese et al., “Histological and virological features and follow-up of hepatitis C virus carriers with normal aminotransferase levels: the Italian prospective study of the asymptomatic C carriers (ISACC),” Journal of Hepatology, vol. 37, no. 1, pp. 117–123, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Cohen, “The scientific challenge of hepatitis C,” Science, vol. 285, no. 5424, pp. 26–30, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. J. A. Chiavetta, M. Escobar, A. Newman et al., “Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990–2000,” Canadian Medical Association Journal, vol. 169, no. 8, pp. 767–773, 2003. View at Google Scholar · View at Scopus
  29. N. Afdhal, J. McHutchison, R. Brown et al., “Thrombocytopenia associated with chronic liver disease,” Journal of Hepatology, vol. 48, no. 6, pp. 1000–1007, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. Blood Screening by Blood Center, Taiwan Blood Services Foundation, 2008, http://www.blood.org.tw/Internet/main/docDetail.aspx?uid=6678&pid=6389&docid=24880.
  31. Blood Screening by Blood Center, Taiwan Blood Services Foundation, 2009, http://www.sc.blood.org.tw/Internet/main/docDetail.aspx?uid=6677&pid=6389&docid=24905.
  32. C. S. Kitchens, “Thrombocytopenia and thrombosis in disseminated intravascular coagulation (DIC),” Hematology American Society of Hematology Education Program, pp. 240–246, 2009. View at Publisher · View at Google Scholar
  33. K. Crapnell, E. D. Zanjani, A. Chaudhuri, J. L. Ascensao, S. S. Jeor, and J. P. Maciejewski, “In vitro infection of megakaryocytes and their precursors by human cytomegalovirus,” Blood, vol. 95, no. 2, pp. 487–493, 2000. View at Google Scholar · View at Scopus
  34. C. Flaujac, S. Boukour, and E. Cramer-Bordé, “Platelets and viruses: an ambivalent relationship,” Cellular and Molecular Life Sciences, vol. 67, no. 4, pp. 545–556, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Terada, M. Baldini, S. Ebbe, and M. A. Madoff, “Interaction of influenza virus with blood platelets.,” Blood, vol. 28, no. 2, pp. 213–228, 1966. View at Google Scholar · View at Scopus
  36. M. A. Chernesky, R. P. B. Larke, and A. G. G. Turpie, “Interaction between viruses and platelets: requirement of haemolytic activity for platelet aggregation induced by paramyxoviruses,” Journal of General Virology, vol. 21, no. 2, pp. 205–213, 1973. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Kahane, A. Dvilansky, L. Estok, I. Nathan, Z. Zolotov, and I. Sarov, “Detection of anti-platelet antibodies in patients with idiopathic thrombocytopenic purpura (ITP) and in patients with rubella and herpes group viral infections,” Clinical and Experimental Immunology, vol. 44, no. 1, pp. 49–56, 1981. View at Google Scholar · View at Scopus
  38. J. Winiarski, “Platelet antigens in varicella associated thrombocytopenia,” Archives of Disease in Childhood, vol. 65, no. 1, pp. 137–139, 1990. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Zahn, N. Jennings, W. H. Ouwehand, and J.-P. Allain, “Hepatitis C virus interacts with human platelet glycoprotein VI,” Journal of General Virology, vol. 87, no. 8, pp. 2243–2251, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Scott, H. J. Reimers, M. A. Chernesky et al., “Effect of viruses on platelet aggregation and platelet survival in rabbits,” Blood, vol. 52, no. 1, pp. 47–55, 1978. View at Google Scholar · View at Scopus
  41. T. Bik, I. Sarov, and A. Livne, “Interaction between vaccinia virus and human blood platelets,” Blood, vol. 59, no. 3, pp. 482–487, 1982. View at Google Scholar · View at Scopus
  42. S. Wang, R. He, J. Patarapotikul, B. L. Innis, and R. Anderson, “Antibody-enhanced binding of dengue-2 virus to human platelets,” Virology, vol. 213, no. 1, pp. 254–257, 1995. View at Publisher · View at Google Scholar · View at Scopus
  43. I. N. Gavrilovskaya, M. Shepley, R. Shaw, M. H. Ginsberg, and E. R. Mackow, “β3 integrins mediate the cellular entry of hantaviruses that cause respiratory failure,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 12, pp. 7074–7079, 1998. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Scaradavou, “HIV-related thrombocytopenia,” Blood Reviews, vol. 16, no. 1, pp. 73–76, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. C.-Y. Dai, C.-K. Ho, J.-F. Huang et al., “Hepatitis C virus viremia and low platelet count: a study in a hepatitis B & C endemic area in Taiwan,” Journal of Hepatology, vol. 52, no. 2, pp. 160–166, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Martell, J. Gomez, J. I. Esteban et al., “High-throughput real-time reverse transcription-PCR quantitation of hepatitis C virus RNA,” Journal of Clinical Microbiology, vol. 37, no. 2, pp. 327–332, 1999. View at Google Scholar · View at Scopus
  47. S. Hamaia, C. Li, and J.-P. Allain, “The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines,” Blood, vol. 98, no. 8, pp. 2293–2300, 2001. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Gu, S. Ghosal, and A. Roy, “Bayesian bootstrap estimation of ROC curve,” Statistics in Medicine, vol. 27, no. 26, pp. 5407–5420, 2008. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus